Related Experiment Video
Updated: Feb 16, 2026
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Sarcomatoid renal cell carcinoma: Biology and treatment advances
Nemer El Mouallem1, Steven C Smith2, Asit K Paul1
1Division of Hematology, Oncology and Palliative Care, Massey Cancer Center, VCU Medical Center, Virginia Commonwealth University, Richmond, VA.
Abstract:
Sarcomatoid transformation in renal cell carcinoma, so called sacromatoid RCC (sRCC), is associated with an aggressive behavior and a poor prognosis. Current therapeutic approaches are largely ineffective. Recent studies looking into the genomic and molecular characterization of sRCCs have provided insights into the biology and pathogenesis of this entity. These advances in molecular signatures may help development of effective treatment strategies. We herein present a review of recent developments in the pathology, biology, and treatment modalities in sRCC.
Insights
Sarcomatoid renal cell carcinoma (sRCC) shows aggressive behavior and poor prognosis, with current treatments being ineffective. Recent molecular insights offer hope for developing novel therapeutic strategies against this challenging cancer.
Area of Science:
- Oncology
- Genitourinary Pathology
- Molecular Biology
Background:
- Sarcomatoid renal cell carcinoma (sRCC) is a rare variant of renal cell carcinoma.
- sRCC is characterized by aggressive clinical behavior and a poor patient prognosis.
- Existing therapeutic options for sRCC have demonstrated limited efficacy.
Purpose of the Study:
- To review recent advancements in understanding the pathology and biology of sRCC.
- To summarize current and emerging treatment modalities for sRCC.
- To highlight the potential of molecular signatures in guiding future treatment strategies.
Main Methods:
- Literature review of recent studies on sRCC.
- Analysis of genomic and molecular characterization data.
- Synthesis of information on pathology, biology, and treatment.
Main Results:
- Genomic and molecular studies have elucidated key aspects of sRCC pathogenesis.
- Understanding molecular signatures is crucial for developing targeted therapies.
- The review consolidates current knowledge on sRCC pathology and treatment.
Conclusions:
- Sarcomatoid transformation in RCC presents significant therapeutic challenges.
- Advances in molecular profiling are paving the way for more effective treatments.
- Further research into molecular signatures is essential for improving sRCC patient outcomes.
More Related Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:57What is Conservation Biology?
02:59Biological Effects of Radiation
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
02:22Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...